Global Biosimilars/follow-on-biologics Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2020 growth of Biosimilars/follow-on-biologics will have significant change from previous year. By the most conservative estimates of global Biosimilars/follow-on-biologics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 9089.2 million in 2019. Over the next five years the Biosimilars/follow-on-biologics market will register a 3.2% CAGR in terms of revenue, the global market size will reach US$ 10300 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars/follow-on-biologics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilars/follow-on-biologics Market Size 2016-2026
2.1.2 Biosimilars/follow-on-biologics Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Biosimilars/follow-on-biologics Segment by Type
2.2.1 Human growth hormone
2.2.2 Human growth hormone
2.2.3 Monoclonal antibodies
2.2.4 Insulin
2.2.5 Interferon
2.2.6 Granulocyte-Colony Stimulating Factor
2.2.7 Others
2.3 Biosimilars/follow-on-biologics Market Size by Type
2.3.1 Global Biosimilars/follow-on-biologics Market Size CAGR by Type
2.3.2 Global Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)
2.4 Biosimilars/follow-on-biologics Segment by Application
2.4.1 Blood disorders
2.4.2 Oncology diseases
2.4.3 Chronic and autoimmune diseases
2.4.4 Growth hormone deficiencies
2.4.5 Others
2.5 Biosimilars/follow-on-biologics Market Size by Application
2.5.1 Global Biosimilars/follow-on-biologics Market Size CAGR by Application
2.5.2 Global Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)
3 Global Biosimilars/follow-on-biologics by Players
3.1 Biosimilars/follow-on-biologics Market Size Market Share by Players
3.1.1 Global Biosimilars/follow-on-biologics Revenue by Players (2019-2021E)
3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2019-2021E)
3.2 Global Biosimilars/follow-on-biologics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biosimilars/follow-on-biologics by Regions
4.1 Biosimilars/follow-on-biologics Market Size by Regions (2016-2021)
4.2 Americas Biosimilars/follow-on-biologics Market Size Growth (2016-2021)
4.3 APAC Biosimilars/follow-on-biologics Market Size Growth (2016-2021)
4.4 Europe Biosimilars/follow-on-biologics Market Size Growth (2016-2021)
4.5 Middle East & Africa Biosimilars/follow-on-biologics Market Size Growth (2016-2021)
5 Americas
5.1 Americas Biosimilars/follow-on-biologics Market Size by Country (2016-2021)
5.2 Americas Biosimilars/follow-on-biologics Market Size by Type (2016-2021)
5.3 Americas Biosimilars/follow-on-biologics Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilars/follow-on-biologics Market Size by Region (2016-2021)
6.2 APAC Biosimilars/follow-on-biologics Market Size by Type (2016-2021)
6.3 APAC Biosimilars/follow-on-biologics Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biosimilars/follow-on-biologics by Country (2016-2021)
7.2 Europe Biosimilars/follow-on-biologics Market Size by Type (2016-2021)
7.3 Europe Biosimilars/follow-on-biologics Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biosimilars/follow-on-biologics by Region (2016-2021)
8.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2016-2021)
8.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Biosimilars/follow-on-biologics Market Forecast
10.1 Global Biosimilars/follow-on-biologics Forecast by Regions (2021-2026)
10.1.1 Global Biosimilars/follow-on-biologics Forecast by Regions (2021-2026)
10.1.2 Americas Biosimilars/follow-on-biologics Forecast
10.1.3 APAC Biosimilars/follow-on-biologics Forecast
10.1.4 Europe Biosimilars/follow-on-biologics Forecast
10.1.5 Middle East & Africa Biosimilars/follow-on-biologics Forecast
10.2 Americas Biosimilars/follow-on-biologics Forecast by Countries (2021-2026)
10.2.1 United States Biosimilars/follow-on-biologics Market Forecast
10.2.2 Canada Biosimilars/follow-on-biologics Market Forecast
10.2.3 Mexico Biosimilars/follow-on-biologics Market Forecast
10.2.4 Brazil Biosimilars/follow-on-biologics Market Forecast
10.3 APAC Biosimilars/follow-on-biologics Forecast by Region (2021-2026)
10.3.1 China Biosimilars/follow-on-biologics Market Forecast
10.3.2 Japan Biosimilars/follow-on-biologics Market Forecast
10.3.3 Korea Biosimilars/follow-on-biologics Market Forecast
10.3.4 Southeast Asia Biosimilars/follow-on-biologics Market Forecast
10.3.5 India Biosimilars/follow-on-biologics Market Forecast
10.3.6 Australia Biosimilars/follow-on-biologics Market Forecast
10.4 Europe Biosimilars/follow-on-biologics Forecast by Country (2021-2026)
10.4.1 Germany Biosimilars/follow-on-biologics Market Forecast
10.4.2 France Biosimilars/follow-on-biologics Market Forecast
10.4.3 UK Biosimilars/follow-on-biologics Market Forecast
10.4.4 Italy Biosimilars/follow-on-biologics Market Forecast
10.4.5 Russia Biosimilars/follow-on-biologics Market Forecast
10.5 Middle East & Africa Biosimilars/follow-on-biologics Forecast by Region (2021-2026)
10.5.1 Egypt Biosimilars/follow-on-biologics Market Forecast
10.5.2 South Africa Biosimilars/follow-on-biologics Market Forecast
10.5.3 Israel Biosimilars/follow-on-biologics Market Forecast
10.5.4 Turkey Biosimilars/follow-on-biologics Market Forecast
10.5.5 GCC Countries Biosimilars/follow-on-biologics Market Forecast
10.6 Global Biosimilars/follow-on-biologics Forecast by Type (2021-2026)
10.8 Global Biosimilars/follow-on-biologics Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Novartis (Sandoz)
11.1.1 Novartis (Sandoz) Company Information
11.1.2 Novartis (Sandoz) Biosimilars/follow-on-biologics Product Offered
11.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Novartis (Sandoz) Main Business Overview
11.1.5 Novartis (Sandoz) Latest Developments
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Information
11.2.2 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Offered
11.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Synthon Pharmaceuticals Main Business Overview
11.2.5 Synthon Pharmaceuticals Latest Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Information
11.3.2 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Offered
11.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Teva Pharmaceutical Industries Main Business Overview
11.3.5 Teva Pharmaceutical Industries Latest Developments
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Information
11.4.2 LG Life Sciences Biosimilars/follow-on-biologics Product Offered
11.4.3 LG Life Sciences Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 LG Life Sciences Main Business Overview
11.4.5 LG Life Sciences Latest Developments
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Information
11.5.2 Celltrion Biocon Biosimilars/follow-on-biologics Product Offered
11.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Celltrion Biocon Main Business Overview
11.5.5 Celltrion Biocon Latest Developments
11.6 Hospira
11.6.1 Hospira Company Information
11.6.2 Hospira Biosimilars/follow-on-biologics Product Offered
11.6.3 Hospira Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Hospira Main Business Overview
11.6.5 Hospira Latest Developments
11.7 Merck Serono (Merck)
11.7.1 Merck Serono (Merck) Company Information
11.7.2 Merck Serono (Merck) Biosimilars/follow-on-biologics Product Offered
11.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Merck Serono (Merck) Main Business Overview
11.7.5 Merck Serono (Merck) Latest Developments
11.8 Biogen idec
11.8.1 Biogen idec Company Information
11.8.2 Biogen idec Biosimilars/follow-on-biologics Product Offered
11.8.3 Biogen idec Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Biogen idec Main Business Overview
11.8.5 Biogen idec Latest Developments
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Information
11.9.2 Genentech (Roche) Biosimilars/follow-on-biologics Product Offered
11.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Genentech (Roche) Main Business Overview
11.9.5 Genentech (Roche) Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Biosimilars/follow-on-biologics Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Human growth hormone
Table 3. Major Players of Erythropoietin
Table 4. Major Players of Monoclonal antibodies
Table 5. Major Players of Insulin
Table 6. Major Players of Interferon
Table 7. Major Players of Granulocyte-Colony Stimulating Factor
Table 8. Major Players of Others
Table 9. Biosimilars/follow-on-biologics Market Size CAGR by Type (2016-2021) & ($ Millions)
Table 10. Global Biosimilars/follow-on-biologics Market Size by Type (2016-2021) & ($ Millions)
Table 11. Global Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)
Table 12. Biosimilars/follow-on-biologics Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 13. Global Biosimilars/follow-on-biologics Market Size by Application (2016-2021) & ($ Millions)
Table 14. Global Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)
Table 15. Global Biosimilars/follow-on-biologics Revenue by Players (2019-2021E) & ($ Millions)
Table 16. Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2019-2021E)
Table 17. Global Biosimilars/follow-on-biologics Key Players Head office and Products Offered
Table 18. Biosimilars/follow-on-biologics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Biosimilars/follow-on-biologics Market Size by Regions 2016-2021 & ($ Millions)
Table 22. Global Biosimilars/follow-on-biologics Market Size Market Share by Regions 2016-2021
Table 23. Americas Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & ($ Millions)
Table 24. Americas Biosimilars/follow-on-biologics Market Size Market Share by Country (2016-2021)
Table 25. Americas Biosimilars/follow-on-biologics Market Size by Type (2016-2021) & ($ Millions)
Table 26. Americas Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)
Table 27. Americas Biosimilars/follow-on-biologics Market Size by Application (2016-2021) & ($ Millions)
Table 28. Americas Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)
Table 29. APAC Biosimilars/follow-on-biologics Market Size by Region (2016-2021) & ($ Millions)
Table 30. APAC Biosimilars/follow-on-biologics Market Size Market Share by Region (2016-2021)
Table 31. APAC Biosimilars/follow-on-biologics Market Size by Type (2016-2021) & ($ Millions)
Table 32. APAC Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)
Table 33. APAC Biosimilars/follow-on-biologics Market Size by Application (2016-2021) & ($ Millions)
Table 34. APAC Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)
Table 35. Europe Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & ($ Millions)
Table 36. Europe Biosimilars/follow-on-biologics Market Size Market Share by Country (2016-2021)
Table 37. Europe Biosimilars/follow-on-biologics Market Size by Type (2016-2021) & ($ Millions)
Table 38. Europe Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)
Table 39. Europe Biosimilars/follow-on-biologics Market Size by Application (2016-2021) & ($ Millions)
Table 40. Europe Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)
Table 41. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Region (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Region (2016-2021)
Table 43. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2016-2021) & ($ Millions)
Table 44. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)
Table 45. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2016-2021) & ($ Millions)
Table 46. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2021)
Table 47. Key and Potential Regions of Biosimilars/follow-on-biologics
Table 48. Key Application and Potential Industries of Biosimilars/follow-on-biologics
Table 49. Key Challenges of Biosimilars/follow-on-biologics
Table 50. Key Trends of Biosimilars/follow-on-biologics
Table 51. Global Biosimilars/follow-on-biologics Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 52. Global Biosimilars/follow-on-biologics Market Size Market Share Forecast by Regions
Table 53. Global Biosimilars/follow-on-biologics Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 54. Global Biosimilars/follow-on-biologics Market Size Market Share Forecast by Type (2021-2026)
Table 55. Global Biosimilars/follow-on-biologics Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 56. Global Biosimilars/follow-on-biologics Market Size Market Share Forecast by Application (2021-2026)
Table 57. Novartis (Sandoz) Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 58. Novartis (Sandoz) Biosimilars/follow-on-biologics Product Offered
Table 59. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 60. Novartis (Sandoz) Main Business
Table 61. Novartis (Sandoz) Latest Developments
Table 62. Synthon Pharmaceuticals Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 63. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Offered
Table 64. Synthon Pharmaceuticals Main Business
Table 65. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Synthon Pharmaceuticals Latest Developments
Table 67. Teva Pharmaceutical Industries Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 68. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Offered
Table 69. Teva Pharmaceutical Industries Main Business
Table 70. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Teva Pharmaceutical Industries Latest Developments
Table 72. LG Life Sciences Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 73. LG Life Sciences Biosimilars/follow-on-biologics Product Offered
Table 74. LG Life Sciences Main Business
Table 75. LG Life Sciences Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. LG Life Sciences Latest Developments
Table 77. Celltrion Biocon Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 78. Celltrion Biocon Biosimilars/follow-on-biologics Product Offered
Table 79. Celltrion Biocon Main Business
Table 80. Celltrion Biocon Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Celltrion Biocon Latest Developments
Table 82. Hospira Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 83. Hospira Biosimilars/follow-on-biologics Product Offered
Table 84. Hospira Main Business
Table 85. Hospira Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Hospira Latest Developments
Table 87. Merck Serono (Merck) Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 88. Merck Serono (Merck) Biosimilars/follow-on-biologics Product Offered
Table 89. Merck Serono (Merck) Main Business
Table 90. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Merck Serono (Merck) Latest Developments
Table 92. Biogen idec Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 93. Biogen idec Biosimilars/follow-on-biologics Product Offered
Table 94. Biogen idec Main Business
Table 95. Biogen idec Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Biogen idec Latest Developments
Table 97. Genentech (Roche) Details, Company Type, Biosimilars/follow-on-biologics Area Served and Its Competitors
Table 98. Genentech (Roche) Biosimilars/follow-on-biologics Product Offered
Table 99. Genentech (Roche) Main Business
Table 100. Genentech (Roche) Biosimilars/follow-on-biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Genentech (Roche) Latest Developments
List of Figures
Figure 1. Biosimilars/follow-on-biologics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilars/follow-on-biologics Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2021)
Figure 7. Biosimilars/follow-on-biologics in Blood disorders
Figure 8. Global Biosimilars/follow-on-biologics Market: Blood disorders (2016-2021) & ($ Millions)
Figure 9. Biosimilars/follow-on-biologics in Oncology diseases
Figure 10. Global Biosimilars/follow-on-biologics Market: Oncology diseases (2016-2021) & ($ Millions)
Figure 11. Biosimilars/follow-on-biologics in Chronic and autoimmune diseases
Figure 12. Global Biosimilars/follow-on-biologics Market: Chronic and autoimmune diseases (2016-2021) & ($ Millions)
Figure 13. Biosimilars/follow-on-biologics in Growth hormone deficiencies
Figure 14. Global Biosimilars/follow-on-biologics Market: Growth hormone deficiencies (2016-2021) & ($ Millions)
Figure 15. Biosimilars/follow-on-biologics in Others
Figure 16. Global Biosimilars/follow-on-biologics Market: Others (2016-2021) & ($ Millions)
Figure 17. Global Biosimilars/follow-on-biologics Market Size Market Share by Application in 2020
Figure 18. Global Biosimilars/follow-on-biologics Revenue Market Share by Player in 2020
Figure 19. Global Biosimilars/follow-on-biologics Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Biosimilars/follow-on-biologics Market Size 2016-2021 ($ Millions)
Figure 21. APAC Biosimilars/follow-on-biologics Market Size 2016-2021 ($ Millions)
Figure 22. Europe Biosimilars/follow-on-biologics Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Biosimilars/follow-on-biologics Market Size 2016-2021 ($ Millions)
Figure 24. Americas Biosimilars/follow-on-biologics Market Size Market Share by Country in 2020
Figure 25. Americas Biosimilars/follow-on-biologics Market Size Market Share by Type in 2020
Figure 26. Americas Biosimilars/follow-on-biologics Market Size Market Share by Application in 2020
Figure 27. United States Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Biosimilars/follow-on-biologics Market Size Market Share by Regions in 2020
Figure 31. APAC Biosimilars/follow-on-biologics Market Size Market Share by Type in 2020
Figure 32. APAC Biosimilars/follow-on-biologics Market Size Market Share by Application in 2020
Figure 33. China Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Biosimilars/follow-on-biologics Market Size Market Share by Countries in 2020
Figure 40. Europe Biosimilars/follow-on-biologics Market Size Market Share by Type in 2020
Figure 41. Europe Biosimilars/follow-on-biologics Market Size Market Share by Application in 2020
Figure 42. Germany Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Type in 2020
Figure 49. Middle East & Africa Biosimilars/follow-on-biologics Market Size Market Share by Application in 2020
Figure 50. Egypt Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Countries Biosimilars/follow-on-biologics Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 56. APAC Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 57. Europe Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 59. United States Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 60. Canada Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 63. China Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 64. Japan Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 65. Korea Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 67. India Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 68. Australia Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 69. Germany Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 70. France Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 71. UK Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 72. Italy Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 73. Russia Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 74. Spain Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 75. Egypt Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 76. South Africa Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 77. Israel Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 78. Turkey Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Figure 79. GCC Countries Biosimilars/follow-on-biologics Market Size 2021-2026 ($ Millions)
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets